NICHD Payline 2026: No Cutoff, 14.1% New R01 Odds

The NIH and NSF funding odds tracker lines NICHD up against every other institute.

NICHD Payline 2026: A Policy, Not a Percentile

NICHD's new R01 success rate was 14.1% in FY2025, and the institute gives no percentile that would tell you whether your score falls inside it. Grantsights checked the NICHD FY2026 funding strategies (opens in a new tab) for a cutoff and found a list of considerations instead. For R01s and every other mechanism, from R03 and R21 to F31, K99 and T32, the page uses nearly the same sentence: NICHD will consider scientific merit, program priorities, portfolio balance and availability of funds.

The page frames these as general guidelines that can shift during the year to reflect directives from Congress and NIH and new program priorities. NICHD says it wants to fund "the largest number of meritorious projects possible" while keeping room for selected priorities and the NIH Unified Funding Strategy.

That strategy is NIH-wide. On its funding decisions page (opens in a new tab), revised November 21, 2025, NIH tells applicants that ICs "will no longer employ these cutoff points in overall impact scores to determine which applications to fund." FY2027 began under a continuing resolution, flagged on NICHD's page as NOT-OD-26-131. A "NICHD payline 2026" number on a forum isn't an NICHD figure.

Early stage investigators get a mention but no number. NICHD says it'll include ESI status "as one of the program priorities" when it considers eligible applicants, under the Next Generation Researchers Initiative. That's softer than an institute that publishes a separate ESI percentile or a target ESI success rate, and NICHD does neither. If you're an ESI, look up your status in eRA Commons well before the review meeting, because NICHD can only weigh a flag that's actually set. The new investigator guide explains how ESI status is assigned and how long it lasts.

NICHD R01 Success Rates, FY2021 to FY2025

NICHD's new R01 success rate stayed between 15.9% and 16.6% from FY2021 through FY2024, then dipped to 14.1% in FY2025. These figures are from NIH's success-rate tables (opens in a new tab):

R01, R21 and R03 columns are from NIH Data Book table 206, and the last column (research project grants, or RPGs) is from table 217. NIH hasn't added FY2026.

By FY2025 standards, NICHD's R01 numbers held up. New R01 awards slipped from 232 to 212, and renewals barely moved (31.0% to 29.3%). For comparison, NIMH's new R01 rate fell to 9.3% and NINDS's to 8.6% in the same year, per the same table (see the NIMH payline and NINDS payline pages).

Money even rose. According to NIH Data Book table 206, NICHD's combined R01 and R37 funding went from $164.6 million in FY2024 to $175.0 million in FY2025, while the average award climbed from $609,766 to $702,812. Part of that likely reflects NICHD paying some awards for several years at once, covered below.

The smaller mechanisms are where NICHD's FY2025 squeeze showed. The R21 rate fell from 18.8% to 10.6% (97 of 916) as applications rose from 725 to 916, and the R03 rate fell from 22.7% to 13.0%. A common mistake at NICHD is picking the R21 because it feels like the easier win. In FY2025 its success rate was lower than the new R01 rate. The R21 grant guide and R03 small grant guide cover when each still fits.

NIH's success rate definition (opens in a new tab) folds a same-year resubmission into its original and credits an R56 conversion as a funded R01. NICHD made 13 R56 awards in FY2025, up from 5 in FY2024 and 1 in FY2021, so the bridge route grew at NICHD while it shrank at NINDS and NIMH.

The 14% Average R01 Cut and the $500,000 Line

NICHD reduces new competing R01s by 14% on average below the peer review recommended level. The policy says the final reduction depends on research scope, comments in the summary statement, the investigator's other support, and program and agency priorities. So the cut on your award could be larger or smaller than 14%.

NICHD gives three reasons it trims budgets: requests have grown significantly, the base of commitments to ongoing grants is large and growing, and NICHD's budget hasn't grown enough to cover both.

Above $500,000, the bar rises. NICHD no longer requires prior approval to submit a large application, but its policy says budgets over $500,000 in direct costs "will be provided only in highly compelling cases," so that NICHD can fund a broad group of investigators across its mission. It also weighs the PI's other support and the institute's budget when setting any award.

Grantsights analysis of NIH RePORTER puts NICHD's typical award about $70,000 under that line. The median first-year direct cost for single-year new NICHD R01 and R37 awards was $429,698 in FY2024, $429,994 in FY2025 and $429,652 in FY2026. In FY2026, 186 of 234 single-year awards came in under $500,000. That median sits next to what a 14% average cut does to a $500,000 request ($430,000), though RePORTER can't show what each awardee asked for, so treat that as a pattern, not proof.

Applicants often underestimate how the cut interacts with staffing. If your aims need every dollar of a $400,000 request, plan for $344,000 and show which work slows down. NICHD also gives no inflationary increases on future-year commitments, though it says it'll accommodate special needs such as equipment and added personnel when possible. The modular budget guide covers how to build out-year budgets.

Full Funding for a Portion of New Awards

NICHD paid 20 new R01 and R37 awards several years at once in FY2025, up from 2 in FY2024, in the RePORTER records Grantsights pulled. The FY2026 policy explains the mechanism: "NICHD may provide full funding for a portion of new competing awards," and it may ask to renegotiate the award term so awardees can spend all the funds.

NIH's FY2025 by-the-numbers post (opens in a new tab) says changes in award counts "were likely due in part to more awards being forward funded than previous years." At NICHD, that's visible in the multi-year counts above. If NICHD offers full funding, read the renegotiated term closely: a shorter project period with all money up front changes how you hire and when you need to show results.

Non-competing grants look stable. NICHD says it'll support FY2026 continuations at 100% of the committed level, which generally reflects no cost-of-living adjustment.

What FY2026 Award Records Show

NICHD made 250 new R01 and R37 awards in FY2026, the most of the three years Grantsights pulled (237 in FY2024 and 216 in FY2025). These are award records only. RePORTER doesn't list applications, so the count isn't a success rate, and the FY2026 Data Book rate isn't out yet.

Timing skewed late. In FY2026, September led with 90 new awards, followed by August and June (52 each) and May (30). In FY2025, August (62) and September (49) led. If your score is near the margin and nothing has arrived by June, the largest award months are still ahead.

The awards spread across many institutions. One hospital in Massachusetts, Massachusetts General Hospital, tied for the FY2026 lead with 9 new awards, alongside the University of Washington and the University of Michigan at Ann Arbor. By state, Massachusetts (34) and California (26) led. In FY2025, the University of Michigan led with 9 and Children's Hospital of Philadelphia had 7. NIH RePORTER (opens in a new tab) shows which NICHD branches funded projects like yours, and the R01 winners and award history page shows who wins R01s across NIH.

NICHD Fellowship and Career Award Odds

NICHD's K23 success rate rose to 38.2% in FY2025 (29 of 76), from 27.6% a year earlier. NIH Data Book tables 203 and 204 give the full set:

The K99 is the exception, and it's the weakest trend in the table. Applications rose from 71 to 90 while awards fell from 30 to 20, which halved the rate. The F32 at 40.5% was among NICHD's best odds in FY2025. K01 and K08 rows are too small to plan around. Cross-institute versions of these numbers sit in the F31 success rate by institute and K award success rates guides.

How to Read an NICHD Score Without a Payline

NICHD funded 212 new R01s out of 1,508 reviewed in FY2025, according to NIH Data Book table 206, and every one of those decisions was made without a published cutoff. Your percentile still tells you how your application ranked against others in its study section. What it no longer tells you is where NICHD will stop.

Three signals help fill that gap. The first is the summary statement: NICHD's policy says the final budget reduction can depend on comments in it, so the text matters to the award amount as well as the funding decision. The second is program fit. NICHD funds across many branches, and an application that matches a stated program priority is better placed than one that only scores well. The third is timing. In FY2026, more than a third of NICHD's new R01 and R37 awards (90 of 250) went out in September alone, so a quiet summer isn't a rejection.

A percentile is an impact score converted to a rank, as the score explainer shows. Interim lists and rumors about where NICHD "is paying" this round aren't official. Ask your program officer if NICHD is still holding the application for this year's funds, and don't start rewriting until you know.

What NICHD's Funding Strategy Doesn't Tell You

NICHD's policy gives a 14% average cut and a $500,000 line, but it doesn't say how either is applied to a given application. The four public sources split the picture:

Three gaps matter. First, "highly compelling" has no definition, so a budget above $500,000 is a red flag unless your program officer has told you the case is strong. Second, the policy doesn't say which NICHD branches get priority this year; that comes from program staff and NICHD's strategic priorities. Third, ESI status is one priority among several, with no published number, so it helps without guaranteeing anything.

Next Action Table for NICHD Applicants

NICHD's 14.1% new R01 rate in FY2025 was one of the steadier numbers at NIH, but it still means 6 in 7 applications missed. Start from the row that fits:

If you're revising, start with the NIH score explainer to see what your percentile measures, then use the summary statement guide and resubmission guide to plan the A1. The NCI payline and NIDDK payline pages show how two other institutes handle the same question. Child health and family research also draws foundation money, and Grantsights grant search finds those funders.

Sources

• NICHD FY2026 funding strategies (opens in a new tab)
• NIH funding decisions and the Unified Funding Strategy (opens in a new tab)
• NIH Data Book success-rate tables (opens in a new tab) (tables 203, 204, 206 and 217)
• NIH success rate definition (opens in a new tab)
• NIH, Fiscal Year 2025 By the Numbers (opens in a new tab)
• NOT-OD-26-059, fiscal policies for FY2026 (opens in a new tab)
• NIH RePORTER (opens in a new tab)

Related Guides

• NIH paylines explained
• NIH R01 grant success rate data
• NIH fellowship grants: F31 and F32
• NIH new investigator guide
• NIH K99/R00 winners and award history